Based on the comparison of the expression of SNORD42 in leukemia cells, CD34+ progenitor cells, monocytes, and granulocytes in patients with primary AML, the expression of SNORD42 in leukemia cells was significantly enhanced. The gene discussed is CD34; the disease is leukemia.